113 related articles for article (PubMed ID: 20557442)
1. Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition.
Ballent M; Lifschitz A; Virkel G; Mate L; Lanusse C
J Vet Pharmacol Ther; 2010 Jun; 33(3):252-9. PubMed ID: 20557442
[TBL] [Abstract][Full Text] [Related]
2. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.
Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C
J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656
[TBL] [Abstract][Full Text] [Related]
3. Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation.
Lifschitz A; Ballent M; Virkel G; Sallovitz J; Lanusse C
J Pharm Pharmacol; 2006 Aug; 58(8):1055-62. PubMed ID: 16872551
[TBL] [Abstract][Full Text] [Related]
4. Loperamide modifies the tissue disposition kinetics of ivermectin in rats.
Lifschitz AL; Virkel GL; Sallovitz JM; Pis A; Imperiale FA; Lanusse CE
J Pharm Pharmacol; 2004 Jan; 56(1):61-7. PubMed ID: 14980002
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments.
Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C
Drug Metab Dispos; 2006 Mar; 34(3):457-63. PubMed ID: 16381664
[TBL] [Abstract][Full Text] [Related]
6. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds.
Moreno L; Ceballos L; Lifschitz A; Bistoletti M; Alvarez L; Lanusse C
Res Vet Sci; 2010 Apr; 88(2):315-20. PubMed ID: 19892381
[TBL] [Abstract][Full Text] [Related]
7. Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses.
Gokbulut C; Cirak VY; Senlik B; Aksit D; Durmaz M; McKellar QA
Vet Parasitol; 2010 May; 170(1-2):120-6. PubMed ID: 20181429
[TBL] [Abstract][Full Text] [Related]
8. Milk excretion of ivermectin and moxidectin in dairy sheep: assessment of drug residues during cheese elaboration and ripening period.
Imperiale FA; Busetti MR; Suárez VH; Lanusse CE
J Agric Food Chem; 2004 Oct; 52(20):6205-11. PubMed ID: 15453688
[TBL] [Abstract][Full Text] [Related]
9. Effect of parasitism on the pharmacokinetic disposition of ivermectin in lambs.
Pérez R; Palma C; Cabezas I; Araneda M; Rubilar L; Alvinerie M
J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):43-8. PubMed ID: 16411909
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
[TBL] [Abstract][Full Text] [Related]
11. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction.
Lifschitz A; Virkel G; Ballent M; Sallovitz J; Lanusse C
Vet J; 2009 Nov; 182(2):261-8. PubMed ID: 18640064
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C
Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of two ivermectin injectable formulations against psoroptic mange in feedlot cattle.
Genchi C; Alvinerie M; Forbes A; Bonfanti M; Genchi M; Vandoni S; Innocenti M; Sgoifo Rossi CA
Vet Parasitol; 2008 Nov; 158(1-2):110-6. PubMed ID: 18819751
[TBL] [Abstract][Full Text] [Related]
14. Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): Possible implications for the establishment of a fish CYP3A induction model.
Li D; Yang XL; Zhang SJ; Lin M; Yu WJ; Hu K
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jan; 147(1):17-29. PubMed ID: 17826359
[TBL] [Abstract][Full Text] [Related]
15. Cattle nematodes resistant to macrocyclic lactones: comparative effects of P-glycoprotein modulation on the efficacy and disposition kinetics of ivermectin and moxidectin.
Lifschitz A; Suarez VH; Sallovitz J; Cristel SL; Imperiale F; Ahoussou S; Schiavi C; Lanusse C
Exp Parasitol; 2010 Jun; 125(2):172-8. PubMed ID: 20109455
[TBL] [Abstract][Full Text] [Related]
16. Breed-related plasma disposition of ivermectin following subcutaneous administration in Kilis and Damascus goats.
Gokbulut C; Bilgili A; Hanedan B; Aksit D; Aksoy AM; Turgut C
Res Vet Sci; 2009 Dec; 87(3):445-8. PubMed ID: 19410269
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of orally administered ivermectin in African elephants (Loxodonta africana): implications for parasite elimination.
Gandolf AR; Lifschitz A; Stadler C; Watson B; Galvanek L; Ballent M; Lanusse C
J Zoo Wildl Med; 2009 Mar; 40(1):107-12. PubMed ID: 19368248
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the long-acting ivermectin formulation in sheep: Further insight into potential pharmacokinetic interactions.
Ballent M; Maté ML; Dominguez P; Virkel G; Albérich M; Lespine A; Lanusse C; Lifschitz AL
J Vet Pharmacol Ther; 2019 Mar; 42(2):189-196. PubMed ID: 30520071
[TBL] [Abstract][Full Text] [Related]
19. The effects of different ages and dosages on the plasma disposition and hair concentration profile of ivermectin following pour-on administration in goats.
Gokbulut C; Cirak VY; Senlik B; Aksit D; McKellar QA
J Vet Pharmacol Ther; 2011 Feb; 34(1):70-5. PubMed ID: 21219347
[TBL] [Abstract][Full Text] [Related]
20. The effect of sesame and sunflower oils on the plasma disposition of ivermectin in goats.
Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
J Vet Pharmacol Ther; 2008 Oct; 31(5):472-8. PubMed ID: 19000267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]